✓ verbatim from the press
Pernambuco received 25,700 doses of the Pneumo 20 vaccine, which protects against 20 serotypes of the pneumococcus bacterium — the cause of pneumonia, meningitis, and severe otitis media. Children under 5 who have not completed their vaccination schedule can now be vaccinated free of charge through the SUS across the state. In the private network, the same vaccine costs over R$ 500 per dose. ✓
Press quotes (2)
"Pernambuco recebeu um lote inicial de 25.700 doses da vacina Pneumo 20, que protege contra 20 sorotipos da bactéria pneumococcus, causadora de doenças graves como pneumonia e meningite."
"Na rede privada, o custo da vacina ultrapassa R$ 500 por dose."
The batch sent to Pernambuco is part of the first 573,700 doses distributed by the Ministry of Health to Brazilian states. The forecast is to provide more than 6.1 million doses throughout 2026. Health Minister Alexandre Padilha announced the national strategy last weekend: "This vaccine protects against 20 types of this bacterium, which is pneumococcus. And because this vaccine is much broader than the one we used, it will also protect against severe pneumonia and meningitis." ✓
Press quotes (2)
"As vacinas destinadas a Pernambuco fazem parte das primeiras 573,7 mil doses já enviadas para os outros estados. A previsão do Ministério da Saúde é disponibilizar mais de 6,1 milhões de doses ao longo deste ano para todo o país."
"Estou muito feliz de a gente poder transformar essa vacinação em realidade. Eu pude ver as primeiras bebezinhas, com dois meses de idade, já sendo protegidas com essa vacina, que é uma vacina que protege contra 20 tipos dessa bactéria, que é o pneumococcus. E como essa vacina é muito mais ampla do que a que a gente utilizava, ela vai proteger ainda, contra pneumonia grave e contra meningite"
Pneumo 20 gradually replaces the Pneumo 10, Pneumo 13, and polysaccharide 23 vaccines, expanding protection against serotypes that most cause invasive pneumonia — especially types 3, 6A, and 19A. During the transition, the basic vaccination schedule includes one dose of Pneumo 20 at 2 months, one dose of Pneumo 10 at 4 months, and a booster of Pneumo 20 at 12 months. After Pneumo 10 stocks are depleted, the schedule will use exclusively the new vaccine. ✓
Press quotes (2)
"Com a chegada da Pneumo 20, o Ministério da Saúde iniciou uma transição gradual para substituir as vacinas pneumocócicas atualmente utilizadas na rede pública. Durante esse período, o esquema básico para crianças seguirá com uma dose da Pneumo 20 aos 2 meses de idade, uma dose da Pneumo 10 aos 4 meses e uma dose de reforço da Pneumo 20 aos 12 meses."
"O diferencial da nova vacina é a ampliação da proteção imunológica, relacionada aos sorotipos que mais causam pneumonia invasiva, especialmente os tipos 3, 6A e 19A"
According to the World Health Organization (WHO), pneumococcal disease is the leading cause of child mortality from preventable disease. In Brazil, between 2023 and 2025, 4,600 cases of pneumococcal meningitis and approximately 1,400 deaths were recorded — a case fatality rate exceeding 30%. Among children under 5, there were 616 cases and 188 deaths in the same period. Anvisa approved the vaccine's registration in December 2023. ✓
Press quotes (2)
"Segundo a Organização Mundial da Saúde (OMS), a doença pneumocócica é a maior causa de mortalidade infantil por doença prevenível. No Brasil, entre 2023 e 2025, foram registrados 4,6 mil casos de meningite pneumocócica e 1,4 mil óbitos no Brasil, o que representa uma taxa de letalidade superior a 30%. Entre crianças menores de 5 anos, foram 616 casos e 188 mortes no mesmo período."
"A Agência Nacional de Vigilância Sanitária (Anvisa) aprovou o registro da vacina em dezembro de 2023."
Pernambuco received 25,700 doses of the Pneumo 20 vaccine as part of an initial batch of 573,700 doses distributed to Brazilian states
The Ministry of Health plans to distribute more than 6.1 million doses of Pneumo 20 throughout 2026
Anvisa approved the registration of the Pneumo 20 vaccine in December 2023, and the first doses began to be administered in the private network in 2025 at a cost exceeding R$ 500
Between 2023 and 2025, Brazil recorded 4,600 cases of pneumococcal meningitis and approximately 1,400 deaths, with a case fatality rate exceeding 30%; among children under 5, there were 616 cases and 188 deaths
Covered by only some sources, or where the accounts diverge.
Covered by only some sources (3)
Pneumo 20 is the fourth immunobiological incorporated into the SUS childhood calendar during the current administration
Between 2024 and October 2025, the SUS recorded more than 34,000 visits related to diseases caused by pneumococcus
The vaccine also acts against otitis media, a condition that can lead to hearing loss and generalized infection
-
What was the pneumococcal vaccination coverage in Pernambuco before the distribution of Pneumo 20?
Why it's still unknown: None of the consulted sources reported the baseline vaccination coverage for the target age group (under 5 years) in Pernambuco or nationally, making it impossible to assess whether the 25,700 doses represent marginal expansion or a material leap in coverage.
-
How many additional serotypes does Pneumo 20 cover compared to Pneumo 13, and what is the evidence of incremental efficacy?
Why it's still unknown: Sources mention that Pneumo 20 protects against 20 serotypes and is 'broader' than previous vaccines, but do not specify how many serotypes Pneumo 13 (the previous conjugate vaccine) covered, nor quantify the technical difference. Incremental efficacy against serotypes 3, 6A, and 19A is cited, but without efficacy data.
-
Has the incorporation of Pneumo 20 into the national calendar been formalized in a Ministry of Health ordinance or technical note?
Why it's still unknown: Sources report that Minister Alexandre Padilha announced the national strategy last weekend and that this is the fourth vaccine incorporated into the SUS childhood calendar in the current administration, but no official document (ordinance, technical note) is cited or linked.
-
When exactly are Pneumo 10 stocks expected to be depleted, and how will the transition be monitored?
Why it's still unknown: Both sources indicate that the transition scheme will be maintained 'until Pneumo 10 stocks are depleted,' but neither provides a date forecast nor mentions mechanisms for monitoring the transition between the two vaccines.